Method of determining fructosamines

Abstract: A method of determining fructosamine, which comprises the steps of : (a) bringing an aqueous liquid specimen into contact with an active oxygen generating substance, (b) bringing a reagent which causes a detectable change in the presence of hydrogen peroxide derived from active oxygen into contact with the product of step (a), and (c) detecting the detectable change caused in step (b).

Description: Technical Field The present invention relates to a method of measurement of fructosamines in an aqueous liquid. Background Art When glucose and protein react in the blood, stable fructosamines are formed through the unstable Shiff bases. The concentration of fructosamines in the blood has correlation with the concentration of glucose in the blood. Further, it is hardly affected by even short-term variations in the glucose concentration. Therefore, it is known to be extremely effective to measure the concentration of fructosamines in the blood so as to diagnose diabetes and monitor the progress of treatment of diabetics. Japanese Examined Patent Publication (Kokoku) No. 1-13062 describes a method for measuring the concentration of fructosamines in a blood sample by using the fact that fructosamines have reducing activity under alkaline conditions and cause a color agent (for example, a tetrazolium salt) to produce color. This method is preferable in the point that it can be applied to an automatic measurement apparatus. However, blood samples contain reducing substances (for example, ascorbic acid, glutathione, and uric acid) in addition to fructosamines. Therefore, it was necessary to perform the measurement after a certain time elapses from the start of the reaction so as to reduce or avoid the effects of these nonspecific reducing substances. Various proposals were made on techniques for eliminating the influence of coexisting substances. For example, Japanese Unexamined Patent Publication No. 63-15168 describes a method for removal of the nonspecific reducing components and turbidity inducing components by making use of a neutral pH value. Further Japanese Unexamined Patent Publication No. 63-304999 describes a method for removing the nonspecific reducing components and turbidity inducing components by uricase or a surface active agent and performing the measurement in a single stage. Further, Japanese Unexamined Patent Publication No. 63-182567 describes a method for measuring fructosamines after performing a step for removing interfering substances in advance and Japanese Unexamined Patent Publication No. 1-108997 describes a method for removing interfering substances by an agent oxidizing enzymes, etc. However, in the methods described in the above patent publications, a tetrazolium salt is used as the optimal coloring agent in the same way as the method described in said Japanese Unexamined Patent Publication No. 1-13062. This tetrazolium salt produces the water insoluble coloring substance, formazan, as a result of a reaction. Formazan easily adheres to equipment of a measuring apparatus and is difficult to remove. Further, the surface active substances coexisting in a liquid sample (for example, lipids and proteins) result in a change of the apparent absorbance of formazan, so the measurement results are affected by lipids and proteins and there was the problem of a reduction in the measurement precision. The present inventors engaged in studies to resolve the above problems and as a result discovered that if a specific compound is brought into contact with fructosamines, active oxygen is produced and hydrogen peroxide is derived from that active oxygen, so by measuring the amount of the hydrogen peroxide, it is possible to measure the fructosamines. The present invention is based on this discovery. Disclosure of Invention Therefore, the present invention relates to a method for measurement of fructosamines in an aqueous liquid characterized by including the steps of: (a) bringing an aqueous liquid sample into contact with one or more active oxygen producing substances; (b) bringing the product of said step (a) into contact with a reagent producing a detectable change in the presence of hydrogen peroxide derived from the active oxygen, and (c) detecting an occurrence of the detectable change of said step (b). Brief Description of Drawings Figure 1 is a graph showing the relationship between the amount of glycosylated albumin and the absorbance. Figure 2 is a graph showing the correlation between the method of the present invention and the conventional HPLC method. Best Mode for Carrying Out the Invention The "active oxygen producing substance" used in the method of the present invention means a compound which can produce active oxygen (O 2 - ) when coming into contact with fructosamines having reducible property. In the method of the present invention, as the active oxygen producing substance, there may be employed, for example, a phenazinium compound of the general formula: wherein, R₁ is a lower alkyl group having 1 to 4 carbon atoms, in particular a methyl or ethyl group, R₂ is a hydrogen atom, a lower alkyl group having 1 to 4 carbon atoms, in particular a methyl or ethyl group, or a lower alkoxyl group having 1 to 4 carbon atoms, in particular a methoxy group, and X₁ is an anion, for example, a lower alkylsulfate having 1 to 4 carbon atoms, in particular methyl or ethyl sulfate. As the phenazinium compound of the formula (1), 1-methoxy-5-methylphenazinium methylsulfate is preferably used. The phenazinium compound of the formula (1) is brought into contact with the sample in a range of pH of 8.5 to 11.0, preferably 9.5 to 10.3. Further, in the method of the present invention, as the active oxygen producing substance, there may be used a bipyridine compound of the general formula: wherein R₃ and R₄ are independently lower alkyl groups having 1 to 4 carbon atoms, in particular methyl or ethyl groups, and X₂ is an anion, for example, a halogen, in particular chlorine or bromine. As the bipyridine compound of the formula (2), 1,1'-dimethyl-4,4'-bipyridirium dichloride [Methyl viologen] is preferably used. The bipyridine compound of the formula (2) is brought into contact with the sample at a range of pH of 8.5 to 11.0, preferably 9.5 to 10.3. Further, in the method of the present invention, as the active oxygen producing substance, there may be employed a 1,4-quinone compound of the general formula: wherein, R₅ is a hydrogen atom or a lower alkyl group having 1 to 4 carbon atoms, particularly a methyl or ethyl group, B₁ and B₂ are each hydrogen atoms or are atoms necessary for forming a benzene ring together with the two carbon atoms in the formula (3). As the 1,4-quinone compound of the formula (3), benzoquinone, 1,4-naphthoquinone, or 2-methyl-1,4-naphthoquinone is preferably used. The 1,4-quinone compound of the formula (3) is brought into contact with the sample in a range of pH of 8.5 to 11.0, preferably 9.5 to 10.5. Further, in the method of the present invention, as the active oxygen producing substance, there may be used a 1,2-quinone compound of the general formula: wherein, B₃ and B₄ are respectively hydrogen atoms or are atoms necessary for forming a benzene ring or a substituted or unsubstituted pyridine ring together with the two carbon atoms in the formula, and B₅ and B₆ are atoms necessary for forming a benzene ring or a substituted or unsubstituted pyrrole ring together with the two carbon atoms in the formula. The substituent optionally present on the pyridine ring or pyrrole ring is, for example, a lower alkyl group having 1 to 4 carbon atoms or carboxyl group. As the 1,2-quinone compound of the formula (4), 1,2-naphthoquinone, 9,10-phenanthrenequinone, or pyrroloquinoline quinone(2,7,9-tricarboxy-1H-pyrrolo[2,3-f]quinoline-4,5-dione) is preferably used. The 1,2-quinone compound of the formula (4) is brought into contact with the sample in a range of pH of 8.5 to 11.0, preferably 9.5 to 10.5. Further, in the method of the present invention, as the active oxygen producing substance, there may be employed a tetrazolium salt of the general formula: wherein, Y is a halogenated phenyl group (in particular a iodophenyl group), a substituted or unsubstituted thiazolyl group (for example, a thiazolyl group monosubstituted or disubstituted with a lower alkyl group having 1 to 4 carbon atoms, in particular, a methyl or ethyl group), or a group of where R₆ is a hydrogen atom or nitro group, R₇ and R₈ are independently lower alkyl groups having 1 to 4 carbon atoms, in particular methyl or ethyl groups, and X₃ and X₄ are independently anions, for example, halogens, in particular chlorines or bromines. As the tetrazolium salt of the formula (5), 3-(p-iodophenyl)-2-(p-nitrophenyl)-5-phenyl-2H tetrazolium chloride [INT], 3-(4,5-dimethyl-2-thiazolyl)-2,5-diphenyl-2H tetrazolium bromide [MTT], or 3,3'-(3,3'-dimethoxy-4,4'-biphenylylene)-bis[2-(p-nitrophenyl)-5-phenyl-2H tetrazolium chloride] [Nitro-TB] is preferably used. The tetrazolium salt of the formula (5) is brought into contact with the sample in a range of pH of 8.5 to 11.0, preferably 9.5 to 10.5. In the method of the present invention, measurement is made of the fructosamines contained in an aqueous liquid, in particular a biological aqueous liquid, such as blood, liquids derived from blood (in particular, serum or plasma) and urine, or a liquid containing tissue extracts. In the method of the present invention, it is preferable to remove the interfering substances optionally present in the sample, before bringing the sample into contact with the active oxygen producing substance. The interfering substances are, for example, reducing substances other than fructosamines (for example, ascorbic acid, glutathione, and uric acid) and turbidity inducing components (for example, chyle). To remove the interfering substances, there may be used known methods, for example, the methods described in Japanese Unexamined Patent Publication No. 63-15168, Japanese Unexamined Patent Publication No. 63-304999, Japanese Unexamined Patent Publication No. 63-182567, or Japanese Unexamined Patent Publication No. 1-108997. For example, the sample may be treated by dialysis or gel filtration desalination or be allowed to stand for a long period (for example, over 30 minutes) so as to remove the interfering substances. Further, it is possible to add an enzyme not affecting an ultimate results of the measurement system of the present invention. For example, it is possible to add ascorbate oxidase to remove the ascorbic acid. Further, it is possible to use a surface active agent (for example, sodium laurylsulfate) to remove the turbidity of the sample or the influence of the chyle. The fructosamine is converted to an enol type having reducing property under alkaline conditions. In the method of the present invention, there may be used any buffers which can render the system alkaline (for example, a pH of 8.5 to 11.0, preferably a pH of 9.0 to 10.5, in particular a pH of 9.5 to 10.3). As the buffer, there may be used, for example, Good's buffer or preferably a carbonate buffer (for example, sodium hydrogencarbonate or sodium carbonate). The sample, the active oxygen producing substance, and the buffer may be brought into contact with each other in any order, but it is preferable to bring the buffer into contact with the sample and then bring the active oxygen producing substance in contact therewith. The buffer is generally used in a concentration of 10 to 500 mM, preferably 20 to 100 mM. The active oxygen producing substance is generally used in a concentration of 10 µM to 4 mM, but the optimum concentration varies depending on the type of the compound used. The phenazinium compound of the formula (1) is generally used in a concentration of 10 µM to 500 µM, preferably 40 µM to 200 µM. The bipyridine compound of the formula (2) is generally used in a concentration of 0.2 mM to 4 mM, preferably 0.5 mM to 2 mM. The 1,4-quinone compound of the formula (3) or the 1,2-quinone compound of the formula (4) is generally used in a concentration of 10 µM to 2 mM, preferably 25 µM to 1 mM. The tetrazolium salt of the formula (5) is generally used in a concentration of 0.1 mM to 2 mM, preferably 0.2 to 1 mM. The contact among the sample, the active oxygen producing substance, and the buffer may be performed at the temperature usually used, that is, room temperature to about 40°C (preferably about 25 to 37°C). If the contact time is increased, the amount of the product increases along therewith, so there is no particular limitation on the contact time. In the case of application to an automatic analysis apparatus or from the viewpoint of precision of measurement, it is preferable that the contact be for at least about 5 minutes. When reducible fructosamines are present in the sample, active oxygen is produced by the fructosamines and the active oxygen producing substance, then the active oxygen derives hydrogen peroxide. When the tetrazolium salt of the formula (5) is used as the active oxygen producing substance, superoxide dismutase (generally 60 µg/ml to 4 mg/ml, preferably 125 µg/ml to 2 mg/ml) is employed so as to derive only hydrogen peroxide without producing a water insoluble formazan dye. The derived hydrogen peroxide is measured by a known method. The "reagent producing a detectable change in the presence of the hydrogen peroxide" derived from the active oxygen comprises (i) a substance having a peroxidizing activity (hereinafter referred to as a peroxidizing activity substance: typically, peroxidase); and (ii) a dyestuff precursor which forms a color or changes color or a substance which emits fluorescence, in the presence of a peroxidizing activity substance. More particularly, a detectable substance A is produced by the following reaction: wherein H₂A (reduced form) is a dyestuff precursor etc., and A (oxidized form: detectable substance) is a dyestuff etc. produced by the oxidation of H₂A. The peroxidizing activity substance is, for example, peroxidase. Peroxidase exists in horseradish, potatoes, fig tree sap, turnip, milk (lactoperoxidase), leukocyte (myeloperoxidase), or microorganisms. Synthetic peroxidase may also be used. As the peroxidizing activity substances other than enzymes, for example, there may be mentioned iron thiocyanate, iron tannate, iron (II) ferrocyanide, and dichromate (potassium chromium sulfate ) absorbed in silica gel. The dyestuff precursor which forms color or changes color in the presence of the peroxidizing activity substance is, for example, a monoamine (aniline or derivatives thereof, o-toluidine, p-toluidine, etc.), diamine (o-phenylene diamine, benzidine, dianisidine, etc.), phenol (phenol, thymol, cresol, naphthol, etc.), polyphenol (catechol, pyrogallolphloroglucinol, etc.), aromatic acids (salicylic acid, pyrocatechinic acid, gallic acid, etc.), leuco dyes (leuco-malechite green, leuco-phenol phthalein, etc.), and also dichlorophenol indole, epinephrine, and bilirubin. According to a preferable embodiment of the present invention, the absorbance at the wavelength of 510 nm is measured within about 2 to 60 minutes after adding a suitable buffer solution (generally pH of 5 to 9) containing peroxidase (generally 2.5 to 50 µg/ml) and, as electron donors, 4-aminoantipyrine and 3-hydroxy-2,4,6-triiodobenzoic acid (generally 0.2 to 2 mM each) to the product of the step (a). As a control, distilled water is used. Further, for the hydrogen peroxide produced, it is also possible to use the light emission method using luminol microperoxidase. Further, it is possible to use the fluorescent method using a fluorescent substance (for example, homovanillic acid). The method of measurement of the present invention may be performed by a one step process wherein all the reagents are brought into contact with each other simultaneously (that is, adding the liquid sample into a system containing the active oxygen producing substance and the reagent producing a detectable change in the presence of hydrogen peroxide), but it is preferable to divide the procedures into two steps. That is, in the first step, the sample is brought into contact with the active oxygen producing substance to derive the hydrogen peroxide and then in the second step a detectable change is produced from the hydrogen peroxide and the degree of change is measured. In the method of the present invention, it is possible to use any standard solution capable of determining the content by the HPLC method [Parker et al., Clinical Chemistry, 27, 669 to 671, 1981; Menez et al., J. Chromatography, 297, 339 to 350, 1984]. For example, it is possible to use the standard solution described in Japanese Examined Patent Publication No. 1-13062 (prepared from albumin and 1-deoxy-1-morpholinofructose) or fructosyl glutamic acid (see specification of Japanese Patent Application No. 1-206721). The principle of measurement of the present invention is based on the fact that in the presence of an oxidized substance, the electrons from a reducing enol form of fructosamines are used for a reaction to produce a peroxide dependent on the oxygen dissolved in solution. For example, in the presence of a suitable oxidized substance (the active oxygen producing substance of the present invention), electrons from the reducing enol form of fructosamines move to the oxygen dissolved in solution and active oxygen (O 2 - ) is produced. Subsequently, the active oxygen produces hydrogen peroxide by a dismutation reaction: 2O 2 - + 2H⁺ - - - - > O₂ + H₂O₂ The dismutation reaction generally proceeds even without the presence of an enzyme etc., but when using a tetrazolium salt as the active oxygen producing substance, it is necessary to use superoxide dismutase so as to prevent a reaction from the tetrazolium salt to the formazane dye and on the other hand, so as to promote the above-mentioned dismutation reaction. The hydrogen peroxide derived by the dismutation reaction may be measured by methods known to persons skilled in the art. Examples The present invention now will be further illustrated by, but is by no means limited to, the following Examples. Example 1 Preparation of Standard Solutions To Ringer's solution containing 0.4 mM glucose (Wako Junyaku), albumin extracted from serum and purified was added in an amount of 4.3 mg/ml. The whole was incubated at 37°C for four days. The amount of the resulting glycosylated albumin was determined by the HPLC method [Parker et al., Clinical Chemistry, 27, 669 to 671, 1981; Menez et al., J. Chromatography, 297, 339 to 350, 1984] as a conversion to 5-hydroxymethyl-2-furfuraldehyde (5-HMF). A series of standard solutions having various concentrations from 10 µM to 200 µM was prepared. Further, distilled water was used as a control. Preparation of Reagents A carbonate buffer solution (20 mM; pH 10.0) containing 0.1 mM 9,10-phenanthrenequinone (9,10-PTQ) was prepared (referred to as a reagent A). A phosphate buffer solution (0.2 M; pH 7.0) containing 2.8 mM 3-hydroxy-2,4,6-triiodobenzoic acid, 2.8 mM 4-aminoantipyrine, 0.55 mM ethylene diamine tetraacetic acid, and 11 µg/ml of peroxidase (derived from horseradish) was prepared (referred to as a reagent B). Measurement Procedure The standard solutions (50µl each) were added to the reagent A (1.1 ml) and a reaction was performed at 37°C for 5 minutes. To the reaction solution, 0.9 ml of the reagent B was added. The mixture was allowed to stand at room temperature for 10 minutes, and the absorbance at a wavelength of 510 nm was measured. A control experiment was also performed using distilled water instead of the standard solutions. The results are shown by the closed circle marks in Fig. 1. Example 2 Preparation of Reagents A carbonate buffer solution (20 mM; pH 9.8) was prepared (referred to as a reagent A). An aqueous solution containing 10 mM 1-methoxy-5-methylphenazinium methylsulfate (1-methoxy PMS) was prepared (referred to as a reagent B). Further, a phosphate buffer solution (0.2 M; pH 7.0) containing 2.8 mM 3-hydroxy-2,4,6-triiodobenzoic acid, 2.8 mM 4-aminoantipyrine, 0.55 mM ethylene diamine tetraacetic acid, and 11 µg/ml of peroxidase was prepared (referred to as a reagent C). Measurement Procedure The standard solutions (50 µl each) prepared in Example 1 were added to the reagent A (1.1 ml) and further 10 µl of the reagent B was added, and a reaction was performed at 37°C for 5 minutes. To the reaction solution, 0.9 ml of the reagent C was added. The mixture was allowed to stand at room temperature for 10 minutes, and the absorbance at a wavelength of 510 nm was measured. A control experiment was also performed using distilled water instead of the standard solutions. The results are shown by the open circle marks in Fig. 1. Example 3 Preparation of Reagents A carbonate buffer solution (10 mM; pH 10.3) containing 0.25 mM 3,3'-(3,3'-dimethoxy-4,4'-biphenylylene)-bis[2-(p-nitrophenyl)-5-phenyl-2H tetrazolium chloride] [Nitro-TB], 0.25 mM 4-aminoantipyrine, and 125 µg/ml of superoxide dismutase (SOD) was prepared (referred to as a reagent A). A phosphate buffer solution (0.1 M; pH 6.0) containing 1.3 mM 3-hydroxy-2,4,6-triiodobenzoic acid, 1.8% Triton®X-100, and 260 µg/ml of peroxidase was prepared (referred to as a reagent B). Measurement Procedure The standard solutions (50 µl each) prepared in Example 1 were added to the reagent A (1.1 ml) and a reaction was performed at 37°C for 5 minutes. To the reaction solution, 0.25 ml of the reagent B was added. The mixture was allowed to stand at room temperature for 10 minutes, and the absorbance at a wavelength of 510 nm was measured. A control experiment was also performed using distilled water instead of the standard solutions. The results are shown by the X marks in Fig. 1. Example 4 Preparation of Reagents A carbonate buffer solution (20 mM; pH 10.0) containing 0.3 mM 2-methyl-1,4-naphthoquinone was prepared (referred to as a reagent A) . A phosphate buffer solution (0.2 M; pH 7.0) containing 2.8 mM 3-hydroxy-2,4,6-triiodobenzoic acid, 2.8 mM 4-aminoantipyrine, 0.55 mM ethylene diamine tetraacetic acid, and 11 µg/ml of peroxidase (derived from horseradish) was prepared (referred to as a reagent B). Measurement Procedure The standard solutions (50 µl each) prepared in Example 1 were added to the reagent A (1.1 ml) and a reaction was performed at 37°C for 5 minutes. To the reaction solution 0.9 ml of the reagent B was added. The mixture was allowed to stand at room temperature for 10 minutes, and the absorbance at a wavelength of 510 nm was measured. A control experiment was also performed using distilled water instead of the standard solutions. The results are shown by the triangle marks in Fig. 1. Example 5 Preparation of Reagents A carbonate buffer solution (20 mM; pH 10.3) including 1 mM methyl viologen was prepared (referred to as a reagent A). A phosphate buffer solution (0.2 M; pH 7.0) containing 2.8 mM 3-hydroxy-2,4,6-triiodobenzoic acid, 2.8 mM 4-aminoantipyrine, 0.55 mM ethylene diamine tetraacetic acid, and 11 µg/ml of peroxidase (derived from horseradish) was prepared (referred to as a reagent B). Measurement Procedure The standard solutions (50 µl each) prepared in Example 1 were added to the reagent A 1.1 ml) and a reaction was performed at 37°C for 5 minutes. To the reaction solution 0.9 ml of the reagent B was added. The mixture was allowed to stand at room temperature for 10 minutes, and the absorbance at a wavelength of 510 nm was measured. A control experiment was also performed using distilled water instead of the standard solutions. The results are shown by the double circles in Fig. 1. Example 6 Serum was drawn from 24 persons and the content of fructosamines therein was measured by the method described in Example 1. Thereafter, the same serum samples were used for the measurement by the HPLC method [Parker et al., Clinical Chemistry, 27, 669 to 671, 1981; Menez et al., J. Chromatography, 297, 339 to 350, 1984] to investigate the correlation between the two methods. The results are shown in Fig. 2. As clear from Fig. 2, a good correlation was recognized and the coefficient of correlation was 0.946. Examples 7 to 10 The procedure described in Example 6 was repeated, but instead of 9,10-phenanthrenequinone, there were used 1-methoxy-5-methylphenazinium (Example 7), 2-methyl-1,4-naphthoquinone (Example 8), nitro-TB and superoxide dismutase (Example 9), and methylviologen (Example 10). The results are shown in the following Table 1. Table 1 Examples Coefficient of correlation Number of samples 7 0.918 24 8 0.924 24 9 0.909 24 10 0.894 24 Industrial Applicability According to the method of measurement of the present invention, no water insoluble color substance is formed, so it is possible to eliminate the problem of dispersion in the measurement values, colored substances adhering to the measurement equipment, etc. Further, interfering substances can be removed without affecting the measurement system, so it is possible to determine the measurement values at any time and further there is no need for measurement at two points. Therefore, it is possible to perform accurate measurement quickly and with a high precision.

Claims: A method for measurement of fructosamines in an aqueous liquid characterized by including the steps of: (a) bringing an aqueous liquid sample into contact with one or more substances which in the presence of fructosamines are capable of reducing the oxygen dissolved to produce active oxygen; (b) bringing the product of said step (a) into contact with a reagent producing a detectable change in the presence of hydrogen peroxide derived from the active oxygen, and (c) detecting an occurrence of the detectable change of said step (b). A process according to claim 1, wherein a phenazinium compound of the general formula: wherein, R₁ is a lower alkyl group having 1 to 4 carbon atoms, R₂ is a hydrogen atom, a lower alkyl group having 1 to 4 carbon atoms or a lower alkoxyl group having 1 to 4 carbon atoms, and X₁ is an anion, is used as the active oxygen producing substance. A process according to claim 1, wherein a bipyridine compound of the general formula: wherein R₃ and R₄ are independently lower alkyl groups having 1 to 4 carbon atoms, and X₂ is an anion, is used as the active oxygen producing substance. A process according to claim 1, wherein a 1,4-quinone compound of the general formula: wherein, R₅ is a hydrogen atom or a lower alkyl group having 1 to 4 carbon atoms, B₁ and B₂ are each hydrogen atoms or are atoms necessary for forming a benzene ring together with the two carbon atoms in the formula, is used as the active oxygen producing substance. A process according to claim 1, wherein a 1,2-quinone compound of the general formula: wherein, B₃ and B₄ are respectively hydrogen atoms or are atoms necessary for forming a benzene ring or a substituted or unsubstituted pyridine ring together with the two carbon atoms in the formula, and B₅ and B₆ are atoms necessary for forming a benzene ring or a substituted or unsubstituted pyrrole ring together with the two carbon atoms in the formula, is used as the active oxygen producing substance. A process according to claim 1, wherein a tetrazolium salt of the general formula: wherein, Y is a halogenated phenyl group, a substituted or unsubstituted thiazolyl group, or a group of where R₆ is a hydrogen atom or nitro group, R₇ and R₈ are independently lower alkyl groups having 1 to 4 carbon atoms, and X₃ and X₄ are independently anions, is used as the active oxygen producing substance. A process according to claim 6, wherein the tetrazolium salt of the general formula (5) is used together with superoxide dismutase. A process according to claim 1, wherein the aqueous liquid sample is a biological aqueous liquid. A process according to claim 1, wherein the reagent producing a detectable change in the presence of hydrogen peroxide comprises a substance having a peroxidizing activity and a dyestuff precursor which forms a color or changes color or a substance which emits fluorescence, in the presence of a substance having a peroxidizing activity. A process according to claim 1, wherein the aqueous liquid sample is added to a system containing the active oxygen producing substance and the reagent producing a detectable change in the presence of hydrogen peroxide, and the occurrence of the detectable change is detected. A process according to claim 1, wherein hydrogen peroxide is derived by bringing the sample into contact with the active oxygen producing substance; the detectable change is caused to occur by hydrogen peroxide; and the occurrence of the detectable change is detected.

Inventors: HAMA MICHIO, NAKAYAMA MICHIYO, TANAKA MITSUNAO, HAMA, MICHIO,, NAKAYAMA, MICHIYO,, TANAKA, MITSUNAO,, HAMA, Michio, c/o Iatron Labor. Inc., NAKAYAMA, Michiyo, c/o Iatron Labor. Inc., TANAKA, Mitsunao, c/o Iatron Labor. Inc.
Applicants: IATRON LAB, IATRON LABORATORIES, INC.
Application year: 1990
Main classification: G01N33
IPC codes: C12Q1, G01N33